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ichard Smith edited the BMJ from 1979 to 2004 
and was its editor-in-chief from 1990. The nine-
ties proved to be a heady time for scientific pub-
lishers and editors. In 1989  Tim Berners-Lee had  pro-
posed a system for information management that would 
share information over the Internet using hypertext. It 
was an idea that needed a network of users, and by mak-
ing the necessary server and browser software available 
patent- and royalty-free, Berners-Lee (now Sir Timothy) 
and his then-employer, CERN (the European Organiza-
tion  for  Nuclear  Research),  effectively  launched  the 
World  Wide  Web  and  a  revolution  in  communications 
and collaboration that has pervaded every area of human 
activity, including the dissemination of medical research. 
In  1994  the  first  commercial  Web  browser,  Netscape 
Navigator, became available. In 1997 the US National Li-
brary of Medicine rendered to the Web its cumbersome 
MEDLINE collection of indexed health sciences articles 
and called it PubMed.  
Smith led his team of intrepid editors down the beach 
and out into this electronic surf. In 1998, in an audacious 
move that at least some editors (included this one) later 
imitated, Smith posted the entire contents of the BMJ on 
the Web, thus making it the only top-tier medical journal 
available “free” to anyone with Web access. The surf was 
up and rising. 
This book, written mainly in 2003 during a two-month 
leave from BMJ (and later updated to 2006), is in part a 
critical examination of the process of turning research into 
information  that  can  be  communicated  to  others:  re-
searchers,  health  care  providers,  the  public,  policy-
makers, and so on. Initial sections give the author’s views 
on the core question — “What and who are medical jour-
nals for?” — and on the well-known issues that medical 
journal editors encounter: research misconduct, conflicts 
of interest, editorial freedom and accountability.  
Although  carefully  documented  (there  are  over  400 
references, a useful compendium for readers new to the 
field) the book is wet with anecdotes and lively personal 
accounts of events. My favourite is an incident concern-
ing the near-sacking in 1956 of Hugh Clegg, then editor 
of the BMJ, over an editorial entitled “The gold-headed 
cane,” which he wrote, as was his custom, “standing up 
while drinking a bottle of claret.” In the first draft, his in-
vective against  the election  for the seventh consecutive 
year of the President of the Royal College of Physicians 
“[became] stronger as his blood alcohol rose [until he] 
compared this election to Caligula electing his horse to 
the Senate.  This image, much treasured  by subsequent 
editors,  disappeared  from  the  final  version.”  Smith  re-
counts other, more recent editor–publisher conflicts  at 
JAMA,  the  New  England  Journal  of  of  Medicine  and 
CMAJ that became visible through the sudden departure, 
one way or another, of top editors.  
The  penultimate  section,  which  contains  Smith’s 
analysis of the ethics of medical journal publishing, ad-
dresses the vested financial interests of both commercial 
corporations such as the giant Reed Elsevier (publisher 
of The Lancet, among many others) and of medical socie-
ties and associations who publish journals. According to 
Smith, both species of publisher achieve (through phar-
maceutical and classified advertising and reprint sales) 
levels of profit that cannot be justified by their costs or by 
the  “value  added”  to  the  research  they  publish.  Smith 
cites the impressive profits of Reed Elsevier and the im-
portant  share  of  this  contributed  by  scientific  content, 
and takes a guess at the revenues of the New England 
Journal of Medicine (owned by the Massachusetts Medi-
cal Society). The fact is that very few people know exactly 
what kind of money is made from the publication of re-
search  that  is  handed  over  by  its  authors,  along  with 
copyright, for no payment.  
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The BMJ must have made money for the British Medi-
cal Association during Smith’s tenure, but how much this 
might have been is not revealed. Nor does Smith tell us 
his reasons for abruptly leaving the journal in 2004 to 
join a health insurance company, the shock of which to 
Smith  admirers  (myself  included)  would  have  been 
matched by the Pope resigning to take up a post with Sil-
vio Berlusconi or Martha Stewart joining the executive of 
a cement company.  
One can speculate that the reasons were ethical. The 
BMA’s decision to deny access to bmj.com to all but pay-
ing customers (research articles are excluded from this 
restriction) could have been motivated only by a desire to 
sustain or increase revenue from print readers by shoring 
up  library  subscriptions  and  to  cultivate  a  revenue 
stream through subscription fees for online readers. But  
Smith’s  analysis  challenges  the  ethics  of  a  publishing 
model whereby association publishers support their own 
interests by raising money  from  pharmaceutical adver-
tisers while the contributing authors (most of whom are 
not  association  members)  are  either  unpaid  or  receive 
only token rewards for their intellectual contributions. 
This is what is wrong with the current system of publi-
cation by most professional societies. The desire to make 
money to further the ends of the society—in essence, a 
lobby group for its professional members—on the backs 
of authors and other contributors who receive no finan-
cial return for their contributions, and by charging uni-
versity  and  public  libraries,  academics  and  the  public 
(who through tax dollars pay for the research being pub-
lished)  prohibitive  subscription  rates  and  download 
charges is both abhorrent and unethical. Smith sharpens 
the point with Swiftian satire: imagine a British Society 
of Lumpology, whose aim is to promote lumpology and 
the research into lumpology that is published in its jour-
nal. The Society defends the profits it receives from its 
journal by saying  that “they support the society...  [and 
that] the existence of the society might be threatened if 
the  profits  disappeared.”  Smith  writes,  “My  answer  is 
that if the society and the research have value then other 
ways will be found to fund them. If they don’t, then they 
shouldn’t be funded anyway. I worry too that some of the 
profits go on the dinners and ceremonies of which such 
societies are usually fond.”  
For Smith (and I think this is correct), it is wise to see 
medical journals and editors as part of a value chain that 
transforms scientific observations and opinions into in-
formation on  which patients and health care  providers 
can  rely  and  that  can  be  used  to  make  a  difference  in 
their  lives.  If  this  is  so,  and  indeed  it  is  (although,  as 
Smith points out, there is another socially important role 
of a general medical journal: that of leadership) then edi-
tors should ask themselves: Who are the competitors in 
this process, and how can a print or even an electronic 
journal avoid joining historical curiosities such as buggy-
whip  factories  or  even,  perhaps,  the  telephone  compa-
nies? His answer is that they can’t. They will be replaced 
by  alternatives  the  like  of  Wikipedia  Medicine,  various 
discussion groups and blogs,  YouTube, just-in-time in-
formation delivery on pocket devices, and so on.  
There is little in Smith’s analysis that is encouraging 
for the conventional model of medical journal publishing. 
The surf is rising with software and hardware that yields 
easier  communication  between  scientists,  readers  and 
policy-makers, the growing field of bundling information 
into reliable summaries (systematic reviews and the like), 
the development of mobile devices providing the oppor-
tunity of getting the right information to the right place 
at the right time and, most importantly, social software 
that permits and encourages the world’s six billion peo-
ple to communicate directly with each other rather than 
through intermediaries such as medical journals.  
The editorial costs of handling a growing amount of 
relevant  medical-  and  health-related  information  may 
soon overwhelm even the deep pockets of large profes-
sional societies and commercial publishers. Increasingly, 
communities of individuals are taking this on (for exam-
ple, the growing medical  pages on Wikipedia and even 
this journal, Open Medicine), driven not by commercial 
goals, but by the desire to exchange ideas and the fun of 
working together.  
Smith is cheering us on.  
  
  
 
Citation: Hoey J. An editorial dissection [book review]. Open Med 
2007;1(3):e123-4. 
Published: 18 September 2007 
Copyright:  This  article  is  licenced  under  the  Creative  Commons  
Attibution–ShareAlike 2.5 Canada License, which means that anyone 
is able to freely copy, download, reprint, reuse, distribute, display  
or perform this work and that the authors retain copyright of their 
work.  Any  derivative  use  of  this  work  must  be  distributed  only  
under a license identical to this one and must be attributed to the 
authors.  Any  of  these  conditions  can  be  waived  with  permission  
from the copyright holder. These conditions do not negate or super-
sede  Fair  Use  laws  in  any  country.  For  further  information  see 
http://creativecommons.org/licenses/by-sa/2.5/ca/ 
 
 